Discover the full management transaction log of Bellevue Life Sciences Acquisition Corp., a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €97.4m. The latest transaction was disclosed on 27 March 2023 (J). Among the most active insiders: Hwang Kuk Hyoun. Every trade is accessible without an account.
12
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.